Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
hLife is Scopus-indexed (Q1, CiteScore 5.5), DOAJ. Published by Elsevier B.V..
Checked against the index lists dated .
ISSN 2949-9283Verify ISSN ↗
Publisher: Elsevier B.V.
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Immunology and Microbiology (miscellaneous) | 7 / 43 | 84th | Q1 |
| Medicine (miscellaneous) | 106 / 466 | 77th | Q1 |
| Microbiology (medical) | 53 / 147 | 64th | Q2 |
| Immunology and Allergy | 98 / 234 | 58th | Q2 |
Not listed in: Web of Science, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2023–present, best quartile Q1, CiteScore 5.5.
hLife is Q1 in Immunology and Microbiology (miscellaneous) (rank 7 of 43), Q1 in Medicine (miscellaneous) (rank 106 of 466) and Q2 in Microbiology (medical) (rank 53 of 147), by CiteScore 2025. It is ranked in 4 subject areas in all.
hLife is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 5.5, quartile Q1, 84th percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 2.077, quartile Q1, with an H-index of 14.
The publisher lists an article processing charge of about US$2,300 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
hLife is published by Elsevier B.V. Its ISSN is 2949-9283.
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
Yes — it is an open-access journal, listed in DOAJ.
hLife has an h-index of 18 and a 2-year mean of 5.44 citations per paper (OpenAlex). Its Scopus CiteScore is 5.5, quartile Q1. On 2-year citations it ranks #3 of 43 Scopus journals in Immunology and Microbiology (miscellaneous).
hLife published 79 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 90 research articles (2025–2026), authors are most often from China (71.3%), United States (10.7%) and Brazil (2.6%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.